Journals / Glokom Katarakt / 2020 / Cilt: 15 - Sayı: 3

Evaluation of Ex-PRESS® Mini Glaucoma Shunt (P 200) Implantation Outcomes In Pseudophakic Eyes

Pages
155–161
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

The complication rate was 14% (3/21) Conclusion: Ex-PRESS shunt surgery in pseudophakic eyes with OAG is effective and safe with low complication rates in reaching target IOPand decreasing antiglaucomatous drug use.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Purpose: To evaluate the outcomes of Ex-PRESS (P 200) mini-glaucoma shunt implantation surgery in pseudophakic eyes with medically uncontrollable open-angle glaucoma (OAG) for effi cacy and safety.
📊
Key Findings & Data:Materials and Methods: Twenty-one eyes of 21 patients who had primary open-angle or pseudoexfoliation glaucoma were undergone Ex-PRESS shunt implantation surgery.
💡
Conclusion & Impact:The complication rate was 14% (3/21) Conclusion: Ex-PRESS shunt surgery in pseudophakic eyes with OAG is effective and safe with low complication rates in reaching target IOPand decreasing antiglaucomatous drug use.
🔬Design:Review & Systematic Survey
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Özet

Purpose: To evaluate the outcomes of Ex-PRESS (P 200) mini-glaucoma shunt implantation surgery in pseudophakic eyes with medically uncontrollable open-angle glaucoma (OAG) for effi cacy and safety. Materials and Methods: Twenty-one eyes of 21 patients who had primary open-angle or pseudoexfoliation glaucoma were undergone Ex-PRESS shunt implantation surgery. Patients with a minimum of 12 months follow-up were included in the study, and fi les were reviewed retrospectively. Preoperative (pre-op) demographic characteristics, intraocular pressure (IOP), visual acuity (VA), the number of medications used were assessed. Postoperative (post-op) 1st, 6th, 12th month IOP, VA, medication use, complete success (CS) (5 ≤IOP ≤18 mmHg without medication and no additional surgical intervention), qualifi ed success (QS) (5 ≤IOP ≤18 mmHg with or without medication) and complications were evaluated. Results: The mean age was 72.3±13.4 (30-86) years; the mean follow-up time was 16.6±3.4 (12-24) months. The mean pre-op IOP was 31.34±8.18 (23-53) mmHg, fi rst month 14.76±5.85, 6th month 14.28±3.62, and 12th month 14.00±4.07 mmHg. Mean IOP reduction was statistically signifi cant in all post-op examinations (P<0.01). Drop in mean IOP was 55% approximately in the 12th month. The mean number of pre-op medications was 3.52±0.51; it decreased signifi cantly to 0.95±1.28 in the 12th month (P<0.01). Pre-op VA was 0.51±0.66, and the 12th month was 0.44±0.72 logMAR. This difference was no statistically signifi cant (P= 0.2). CS rate was 57%, and the QS rate was 90.5% in 12th months. The complication rate was 14% (3/21) Conclusion: Ex-PRESS shunt surgery in pseudophakic eyes with OAG is effective and safe with low complication rates in reaching target IOPand decreasing antiglaucomatous drug use.

🔖

Cite This Article

OZBILEN, K. T., ALTINKURT, E., CEYLAN, N. A., ASICI, A., YILMAZLI, M. C. (2020). Evaluation of Ex-PRESS® Mini Glaucoma Shunt (P 200) Implantation Outcomes In Pseudophakic Eyes. Glokom Katarakt, Cilt: 15 - Sayı: 3, 155–161. https://ajindex.com/articles/157139

References (14)

  1. European Glaucoma Society, Terminology and guidelines for glaucoma, Chapter 2, page 79, 4th edition, 2014
  2. Kanner EM, Netland PA, Sarkisian SR Jr et al. Ex-PRESS miniature glaucoma device implanted under a scleral fl ap alone or combined with phacoemulsifi cation cataract surgery. J Glaucoma 2009;18:488-91
  3. De Jong L, Lafuma A, Aguadé A-S, et al. Five-year extension of a clinical trial comparing the EX-PRESS glaucoma fi ltration device and trabeculectomy in primary open-angle glaucoma. Clinical Ophthalmology 2011:5 527-533
  4. Bustros YD, Fechtner R, Khouri AS. Outcomes of Ex- PRESS and Trabeculectomy in a Glaucoma Population of African Origin: One Year Results. J Curr Glaucoma Pract 2017;11:42-7
  5. Dahan E, Ben Simon GJ. Lafuma A. Comparison of trabeculectomy and Ex-PRESS implantation in fellow eyes of the same patient: a prospective, randomised study. Eye (Lond). 2012;26:703-10
  6. Williams VA, Momi R, Tannir J, et al. Short term safety and effi cacy of P200 versus P50 Ex-PRESS shunt. Invest. Ophthalmol. Vis. Sci. 2012; 53:3732
  7. Samsudin A, Eames I, Brocchini S. et al. Evaluation of dimensional and fl ow properties of ExPress glaucoma drainage devices. J Glaucoma 2016;25:39-45
  8. Arimura S Takihara Y Miyake S. et al. Randomized Clinical trial for early postoperative complications of Ex-PRESS implantation versus trabeculectomy: complicationspostoperatively of Ex-PRESS versus trabeculectomy. Sci Rep. 2018; 8: 16168
  9. Gandolfi S, Traverso CF, Bron A. et al. Short-term results of a miniature draining implant for glaucoma in combined surgery with phacoemulsifi cation. Acta Ophthalmol Scand Suppl 2002;236:66
  10. Dahan E, Carmichael TR. Implantation of a miniature glaucoma device under a scleralfl ap. J Glaucoma 2005;14:98- 102
  11. Traverso CE, De Feo F, Messas-Kaplan A. et al. Longterm effect on IOP of a stainless steel glaucoma drainage implant (Ex-PRESS) in combined surgery with phacoemulsifi cation. Br J Ophthalmol 2005;89:425-9
  12. Konopinska J, Deniziak M, Saeed E, et al. Prospective randomized study comparing combined phaco-ExPress and phacotrabeculectomy in open-angle glaucoma treatment: 12-Month follow-up. J Ophthalmol. 2015;2015:720109
  13. Han G, Zhou H, Zhang W, et al. Early effectiveness of P50 and P200 Ex-PRESS glaucoma drainage device implantation for open-angle glaucoma: a randomized controlled study. Zhonghua Shiyan Yanke Zazhi/Chinese Journal of Experimental Ophthalmology 2015; 33:246-9
  14. Netland PA, Sarkisian SR, Moste